| 000 | 01693 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250517051004.0 | ||
| 264 | 0 | _c20160609 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1537-6591 | ||
| 024 | 7 |
_a10.1093/cid/civ528 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCardona, Amilcar F | |
| 245 | 0 | 0 |
_aSkin and soft-tissue infections: a critical review and the role of telavancin in their treatment. _h[electronic resource] |
| 260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _cSep 2015 |
||
| 300 |
_aS69-78 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAminoglycosides _xpharmacology |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aDaptomycin _xpharmacology |
| 650 | 0 | 4 |
_aGram-Negative Bacterial Infections _xdrug therapy |
| 650 | 0 | 4 |
_aGram-Positive Bacterial Infections _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLipoglycopeptides |
| 650 | 0 | 4 |
_aMethicillin-Resistant Staphylococcus aureus _xdrug effects |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aNorth America _xepidemiology |
| 650 | 0 | 4 |
_aOxazolidinones _xpharmacology |
| 650 | 0 | 4 |
_aSkin Diseases, Bacterial _xdrug therapy |
| 650 | 0 | 4 |
_aSoft Tissue Infections _xdrug therapy |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xdrug therapy |
| 700 | 1 | _aWilson, Samuel E | |
| 773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 61 Suppl 2 _gp. S69-78 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/cid/civ528 _zAvailable from publisher's website |
| 999 |
_c25210859 _d25210859 |
||